These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35978886)

  • 1. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
    Liu H; Zhang H; Fan H; Tang S; Weng J
    Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
    Zhang L; Lin S; Zhang Z; Yan C; Liu F
    Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
    Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
    Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.